Purpose to award the contract for toxicological evaluations of potential medications, period of performance: 09/07/2018- 09/06/2023. Nida REF. No. N01DA-18-8939
Ended Basic Ordering Agreement Awarded Last action
- Contract number
- 75N95018G00019
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 6 $5,280,914 obligated
Award facts
- Opportunity
-
- Toxicological Evaluations of Potential Medications Pre-Solicitation · NIHDA201800011 · Posted Dec 4, 2017
- Combined order value
- $5,280,914 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 54% used
- $9,750,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institutes of Health (NIH), through its National Institute on Drug Abuse (NIDA), has awarded a Basic Ordering Agreement (BOA) contract to Sri International, a nonprofit research and development institute. The purpose of this $9.75 million, single-award IDV contract is to conduct toxicological evaluations of potential medications to support NIDA's drug abuse research program.
Under this IDV, NIDA has issued several cost-plus-fixed-fee task orders to Sri International, valued at over $4.7 million in total. The task orders are for preclinical toxicology and safety studies on potential drug treatments, including interaction safety studies in rats and dogs, as well as cardiovascular safety evaluations. The work is being performed at Sri International's facilities in West Menlo Park, California. This IDV does not utilize any small business set-asides, given Sri International's large size and nonprofit status. The period of performance for the BOA and related task orders runs through September 2023.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Show all 11
Quick answers
Who was awarded contract 75N95018G00019?
75N95018G00019 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on September 7, 2018.
How much is contract 75N95018G00019 worth?
Orders under 75N95018G00019 have obligated $5,280,914. 75N95018G00019's own ceiling is $9,750,000.
How many orders have been placed under contract 75N95018G00019?
6 orders have been placed under 75N95018G00019, the latest on November 17, 2021.
Who can order from contract 75N95018G00019?
75N95018G00019 is a single award basic ordering agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV